Ilsung Pharm Free Cash Flow Generation Index
Ilsung Pharm free cash flow generation index. Ilsung Pharm (003120) has a Free Cash Flow Generation Index of -4.88x as of June 2026. Free cash flow of ₩-606.79 Million represents -5% of operating cash flow (₩124.28 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Ilsung Pharm (2013–2025)
Free cash flow generation index of Ilsung Pharm from 2013 to 2025. Historical FCF Generation Index trend for Ilsung Pharm across 9 annual periods. See Ilsung Pharm leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Ilsung Pharm Free Cash Flow Generation Index by Year (2013–2025)
Ilsung Pharm free cash flow generation index by year from 2013 to 2025. Year-by-year Free Cash Flow Generation Index for Ilsung Pharm. For the full cash flow conversion analysis, see cash efficiency ratio of Ilsung Pharm.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | ₩1.71 Billion | ₩3.88 Billion | ₩2.18 Billion | ▲ +136.3% |
| 2021 | -1.21x | ₩-6.91 Billion | ₩5.70 Billion | ₩10.93 Billion | ▲ +42.1% |
| 2020 | -2.09x | ₩-3.26 Billion | ₩1.56 Billion | ₩4.82 Billion | ▼ -391.8% |
| 2019 | 0.72x | ₩3.15 Billion | ₩4.39 Billion | ₩1.24 Billion | ▼ -21.3% |
| 2018 | 0.91x | ₩13.76 Billion | ₩15.09 Billion | ₩1.21 Billion | ▲ +11.5% |
| 2017 | 0.82x | ₩8.31 Billion | ₩10.16 Billion | ₩1.85 Billion | ▼ -44.4% |
| 2015 | 1.47x | ₩8.89 Billion | ₩6.04 Billion | ₩2.85 Billion | ▲ +20.1% |
| 2014 | 1.23x | ₩5.14 Billion | ₩4.19 Billion | ₩945.31 Million | ▲ +0.2% |
| 2013 | 1.22x | ₩6.19 Billion | ₩5.06 Billion | ₩1.13 Billion | — |